Bottom line
EIRRX vs FJAN: the short answer
EIRRX (Eaton Vance Short Duration Inflation-Protected Income Fund) and FJAN (FT Vest U.S. Equity Buffer ETF - January) are both mutual funds.
But FJAN is far broader, holding 17 positions to 4 for EIRRX, so beyond the top names it adds exposure EIRRX doesn't have.
EIRRX is cheaper at 0.76% vs 0.85% — a difference of $9.00 a year per $10,000 invested.
Over one year, FJAN returned +15.4% vs +5.7% for EIRRX (reporting dates differ).
Updated Nov 19, 2026
EIRRX vs FJAN side by side
| EIRRX | FJAN | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | First Trust |
| Category | Buffer / Defined Outcome | Buffer / Defined Outcome |
| Expense ratio | 0.76% | 0.85% |
| Annual cost per $10k | $76 | $85 |
| 10-yr cost on $10k (prospectus) | $1,117 | — |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +5.7% | +15.4% |
| 5-yr return (annualized) | +4.4% | — |
| 10-yr return (annualized) | +4.1% | — |
| Best quarter | — | +9.0% |
| Worst quarter | — | −10.8% |
| Net assets (fund) | $549.1M | $1.4B |
| Number of holdings | 4 | 17 |
| Portfolio turnover | 16% | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
EIRRX and FJAN share none of their top holdings.
EIRRX top 10
- Short Duration Inflation-Protected Income Portfolio — 74.07%
- Senior Debt Portfolio (MA) — 21.12%
- Eaton Vance Short Duration Income ETF — 3.70%
- Eaton Vance Ultra-Short Income ETF — 1.10%
FJAN top 10
- Cboe Global Markets, Inc. — 87.79%
- Cboe Global Markets, Inc. — 8.13%
- Cboe Global Markets, Inc. — 5.05%
- Cboe Global Markets, Inc. — 2.10%
- Cboe Global Markets, Inc. — 0.98%
- Dreyfus Government Cash Management Funds — 0.83%
- Cboe Global Markets, Inc. — 0.20%
- Cboe Global Markets, Inc. — 0.12%
- Cboe Global Markets, Inc. — 0.02%
- Cboe Global Markets, Inc. — -0.01%
FAQ
What is the difference between EIRRX and FJAN?
Which is cheaper, EIRRX or FJAN?
Should I own both EIRRX and FJAN?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.